REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Comision Nacional Para El Desarrollo Y Vida Sin Drogas (Peru)

Main Activities: Ambulatory Health Care Services
Full name: Comision Nacional Para El Desarrollo Y Vida Sin Drogas Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Comision Nacional Para El Desarrollo Y Vida Sin Drogas is a Peruvian company, incorporated in 01/01/1997. It is headquartered in the city of Lima and is engaged in Ambulatory Health Care Services.

Headquarters
Av. Alfredo Benavides 2199, Of. B, Miraflores
Lima; Lima;

Contact Details: Purchase the Comision Nacional Para El Desarrollo Y Vida Sin Drogas report to view the information.

Basic Information
Total Employees:
Purchase the Comision Nacional Para El Desarrollo Y Vida Sin Drogas report to view the information.
Outstanding Shares:
Purchase the Comision Nacional Para El Desarrollo Y Vida Sin Drogas report to view the information.
Incorporation Date:
January 01, 1997
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Chief
Purchase this report to view the information.
Chief
Company Performance
Financial values in the chart are available after Comision Nacional Para El Desarrollo Y Vida Sin Drogas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PEN. Absolute financial data is included in the purchased report.
Net sales revenue
-3.1%▼
Total operating revenue
-3.1%▼
Net Profit (Loss) for the Period
67.73%▲
Total assets
-1.4%▼
Total equity
-11.16%▼
Net Profit Margin
2.08%▲
Return on Equity (ROE)
21.86%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo